Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gregory J Divis Insider Profile
11 Followers
Gregory J Divis, CEO, Director at Avadel Pharmaceuticals, holds 169.10K shares in Avadel Pharmaceuticals (Ticker: AVDL), holds 12.13K shares in Jaguar Animal Health (Ticker: JAGX). Most recently, Gregory J Divis Bought ― shares of Avadel Pharmaceuticals on Dec 10, 2024 for an estimated value of 99.64K.
Gregory J Divis Avadel Pharmaceuticals (AVDL)CEO, Director
Avadel Pharmaceuticals (AVDL)
CEO, Director
Ranked #5,403 out of 99,797 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+163.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gregory J Divis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 31, 2022 - May 31, 2023
Return:+526.60%
The most profitable trade made by Gregory J Divis
Gregory J Divis's Trading History
Avadel Pharmaceuticals
Dec 10, 2024
CEO, Director
Informative Buy
99.64K
$1.74M
Jaguar Animal Health
May 18, 2022
Director
Uninformative Buy
4.73K
$11.22K
List of latest transactions for each holding click on a transaction to see Gregory J Divis's performance on stock
You May Also Like
Gregory J Divis insider profile FAQ
What is the percentage of profitable transactions made by Gregory J Divis?
The percentage of profitable transactions made by Gregory J Divis is 67%.
What is the average return per transaction made by Gregory J Divis?
The average return per transaction made by Gregory J Divis is 163.30%.
What stocks does Gregory J Divis hold?
Gregory J Divis holds: AVDL, JAGX stocks.
What was Gregory J Divis’s latest transaction?
Gregory J Divis latest transaction was an Informative Buy of $99.64K.
What was Gregory J Divis's most profitable transaction?
Gregory J Divis’s most profitable transaction was an Informative Buy of AVDL stock on May 31, 2022. The return on the trade was 526.60%.
What is Gregory J Divis's role in Avadel Pharmaceuticals?
Gregory J Divis's role in Avadel Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.